Doctors and drug companies: Is the dangerous liaison drawing to an end?

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)


The Introduction and Overview will contain a bold statement of the essay themes. Next the section on Entanglement will look at the many forms of doctor-drug company relationships, and the evidence for how these can distort practice. Selling Sickness will briefly explore the way doctor-drug company relationships are important to the widening of boundaries of treatable illness. And finally, Disclosure to Disentanglement will look at self-regulatory and statutory attempts around the world to get more independence in the relationship between doctors and drug companies.

Original languageEnglish
Pages (from-to)141-148
Number of pages8
JournalZeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
Issue number3
Publication statusPublished - 2009
Externally publishedYes


Dive into the research topics of 'Doctors and drug companies: Is the dangerous liaison drawing to an end?'. Together they form a unique fingerprint.

Cite this